Spectral Medical Inc.
TSX:EDT.TOMedical - Diagnostics & Research
-$0.02 today
- Market cap
- $306.00M
- Beta
- 0.23
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.13
Volume 0.02M
Average 0.06M
Dividends
Spectral Medical Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
Special
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
1Y Growth
—
3Y CAGR
—
5Y CAGR
—
Dividend Payments, Annual Total (TTM) & Yield
Analysis
The current indicated dividend yield is 0.00%, with TTM dividends of $0.12 per share. The payout ratio is 0.0%, so compare payout growth against earnings coverage. Payments are currently special.
Competitor dividends
How does Spectral Medical Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Eupraxia Pharmaceuticals Inc. TSX:EPRX.TO | $783.37M | 0.00% | $0.00 | 0.00% | 0.00% |
Kneat.com, Inc. TSX:KSI.TO | $624.86M | 0.00% | $0.00 | 0.00% | 0.00% |
Fennec Pharmaceuticals Inc. TSX:FRX.TO | $580.71M | 0.00% | $0.00 | 0.00% | 0.00% |
Aurora Cannabis Inc. TSX:ACB.TO | $463.50M | 0.00% | $0.00 | 0.00% | 0.00% |
Profound Medical Corp. TSX:PRN.TO | $388.24M | 0.00% | $0.00 | 0.00% | 0.00% |
Canopy Growth Corporation TSX:WEED.TO | $364.19M | 0.00% | $0.00 | 0.00% | 0.00% |
Cipher Pharmaceuticals Inc. TSX:CPH.TO | $360.13M | 0.00% | $0.00 | 0.00% | 1.63% |
Questions
Dividend questions
Common questions about EDT.TO's dividend, answered from reported figures.
Does EDT.TO stock pay dividends?
Spectral Medical Inc. (EDT.TO) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is EDT.TO's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.